Kevin Muir's most recent trade in Delcath Systems Inc was a trade of 113,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 7, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Delcath Systems Inc | Kevin Muir | GM INTERVENTIONAL ONCOLOGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 113,000 | 113,000 | - | - | Stock Option (Right to Buy) | |
Delcath Systems Inc | Kevin Muir | GM INTERVENTIONAL ONCOLOGY | Grant, award, or other acquisition of securities at price $ 3.72 per share. | 19 Mar 2024 | 13,441 | 18,582 (0%) | 0% | 3.7 | 50,001 | Common Stock |
Delcath Systems Inc | Muir Kevin | VP COMMERCIAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 100,500 | 100,500 | - | - | Stock Option (Right to Buy) | |
Delcath Systems Inc | Kevin Muir | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 59,813 | 59,813 | - | - | Stock Option (Right to Buy) | |
Delcath Systems Inc | Muir Kevin | VP COMMERCIAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 46,800 | 46,800 | - | - | Stock Option (Right to Buy) |